Evidence map›Paper›PMID 19036793›Full record

ArticleNucleic acids research2009

Functional and structural characterization of the integrase from the prototype foamy virus.

Eugene Valkov, Saumya Shree Gupta, Stephen Hare, Anna Helander, Pietro Roversi, Myra McClure, Peter Cherepanov

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Review
  3. The Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario.International journal of molecular sciences · 2023
    Review
  4. Structure and function of retroviral integrase.Nature reviews. Microbiology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Foamy Virus Integrase in Development of Viral Vector for Gene Therapy.Journal of microbiology and biotechnology · 2020
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Prototype foamy virus integrase is promiscuous for target choice.Biochemical and biophysical research communications · 2018
    Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eugene ValkovDivision of Medicine, St. Mary's Campus, Imperial College London, London, UK.
Saumya Shree Gupta
Stephen Hare
Anna Helander
Pietro Roversi
Myra McClure
Peter Cherepanov
Imperial College London · GBSt Mary's Hospital · GB

Funding

Medical Research Council G0400389Medical Research Council G0500367Medical Research Council G0600009
6 · The paper itself

Abstract

Establishment of the stable provirus is an essential step in retroviral replication, orchestrated by integrase (IN), a virus-derived enzyme. Until now, available structural information was limited to the INs of human immunodeficiency virus type 1 (HIV-1), avian sarcoma virus (ASV) and their close orthologs from the Lentivirus and Alpharetrovirus genera. Here, we characterized the in vitro activity of the prototype foamy virus (PFV) IN from the Spumavirus genus and determined the three-dimensional structure of its catalytic core domain (CCD). Recombinant PFV IN displayed robust and almost exclusively concerted integration activity in vitro utilizing donor DNA substrates as short as 16 bp, underscoring its significance as a model for detailed structural studies. Comparison of the HIV-1, ASV and PFV CCD structures highlighted both conserved as well as unique structural features such as organization of the active site and the putative host factor binding face. Despite possessing very limited sequence identity to its HIV counterpart, PFV IN was sensitive to HIV IN strand transfer inhibitors, suggesting that this class of inhibitors target the most conserved features of retroviral IN-DNA complexes.

Indexed as

Amino Acid SequenceAnimalsCatalytic DomainCell LineCrystallographyDogsEnzyme InhibitorsHumansIntegrasesModels, MolecularMolecular Sequence DataRecombinant ProteinsSequence Analysis, DNASpumavirusViral ProteinsEnzyme InhibitorsIntegrasesRecombinant ProteinsViral Proteins

Identifiers

PMID19036793
PMCPMC2615609
OpenAlexW2001281718

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.